LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe Psoriasis

NCT03254667 · clinicaltrials.gov ↗

ENROLLING_BY_INVITATION

Status

3500

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

BIOLOGICAL: Brodalumab
DRUG: Comparator Drug (non-biologic IL-17 inhibitors)

Sponsor

Bausch Health Americas, Inc.